Navigation Links
Bristly spheres as capsules
Date:3/6/2009

This release is available in German.

Amphiphilic molecules, which have one water-friendly (hydrophilic) end and one water-repellant (hydrophobic) end, spontaneously aggregate in aqueous solutions to make superstructures like capsules or bilayers. This phenomenon is responsible for the effects of detergents and soaps. Dirt is enclosed in little capsules of surfactant, which makes it water-soluble. Cell membranes are also based on this principle: they are simply lipid bilayers, an aggregation of lipid molecules that line up with their hydrophobic tails all together and their hydrophilic heads protruding into the aqueous environment. As reported in the journal Angewandte Chemie, researchers at the Universities of Hamburg and Freiburg (Germany) led by Horst Weller and Stephan Frster have now produced amphiphilic hybrid particles made of a water-insoluble inorganic nanoparticle at the core surrounded by a bristle-like layer of hydrophilic polymer chains.

The inorganic nanoparticles are made of cadmium selenide and cadmium sulfide. Polyethylene oxide chains are attached to the nanoparticles through amino groups. The nature of the superstructures formed in aqueous solution depends on how densely the surfaces of the little spheres are covered with the polymer "bristles". If they are densely packed, the hybrid particles remain in solution as individuals, because the bristles repel each other. If the bristles are less dense, dimers and trimers are formed; still sparser bristles result in long wormlike aggregates of many particles that grow into a network through occasional Y-shaped branches. For the particles to aggregate in this way, the bristles on the surfaces of the inorganic cores have to reorganize significantly: they move aside a little to free up points of contact so the cores can attach to each other. Aggregation then continues until the resulting ensemble of cores is, as a whole, surrounded by a sufficiently dense layer of bristles, which acts as a shield toward additional particles.

Cores with an even smaller number of polymer bristles aggregate into extended curved layers that close themselves off into capsule-shaped vesicles. The walls of the vesicles consist of a monolayer of the bristly particles.

The polymer-coated spheres offer a new, simple method for the controlled production of superstructures. The vesicles could be used to encapsulate drugs, for example, as contrast agents, or as ordered liquid crystalline phases for the production of nanostructured hybrid materials.


'/>"/>

Contact: Stephan Foerster
forster@chemie.uni-hamburg.de
49-404-283-83460
Wiley-Blackwell
Source:Eurekalert  

Related biology technology :

1. First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
2. SoluLinK Introduces NanoLink(TM) Streptavidin Magnetic Microspheres
3. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
4. FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD
5. China Pharma Holdings, Inc. Receives SFDA Production Approval for Tiopronin Enteric-Coated Capsules
6. Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
7. NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules
8. Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules
9. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
10. Ranbaxy Launches Omeprazole 40 mg Capsules
11. Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bristly spheres as capsules
(Date:2/27/2017)... Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: IMLFF), reported today that ... total of 10,672,750 common share purchase warrants have been exercised ... the exercise of these warrants totalled $1,387,458 and 10,672,750 common ... ... expression of confidence by our warrant holders. This infusion of ...
(Date:2/27/2017)... HAMILTON, Bermuda , Feb. 27, 2017 /PRNewswire/ ... ) and SELLAS Life Sciences Group , ... immunotherapies, today announced that Advaxis has granted SELLAS ... agent using Advaxis, proprietary Lm -based antigen ... peptide antigen mixture (galinpepimut-S). Advaxis, ...
(Date:2/27/2017)... , ... February 27, 2017 , ... The Catalyst ... a few in the Midwest offering premix services and private label organic services. , ... laying hens, according Jos Zamzow, chief operating officer of Dynamite Marketing, which owns the ...
(Date:2/24/2017)... MA (PRWEB) , ... February 24, 2017 , ... ... replacement (TDR) procedures can be safely completed in an ambulatory surgery center (ASC) ... fusion (ACDF) procedures and previous two-year TDR studies. , Jake Lubinski, president ...
Breaking Biology Technology:
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/1/2017)... 2017 IDTechEx Research, a leading provider of ... the availability of a new report, Sensors for Robotics: Technologies, ... Reading ... ... Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: ...
(Date:1/26/2017)... PANAMA CITY , Jan. 26, 2017  Crossmatch, ... today unveiled a new solution aimed at combatting fraud, ... The solution was introduced at the Action on Disaster ... a key meeting point for UN agencies and foreign ... Fraud, waste and abuse are a largely ...
Breaking Biology News(10 mins):